Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Monika Herian & Paweł Świt. (2023) 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review. Critical Reviews in Toxicology 53:1, pages 15-33.
Read now
Read now
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Read now
Articles from other publishers (35)
Kateřina Syrová, Klára Šíchová, Hynek Danda, Eva Lhotková, Pascal Jorratt, Nikola Pinterová-Leca, Čestmír Vejmola, Lucie Olejníková-Ladislavová, Kateřina Hájková, Martin Kuchař, Jiří Horáček & Tomáš Páleníček. (2023) Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats—pharmacokinetics, effects on behaviour and thermoregulation. Frontiers in Pharmacology 14.
Crossref
Crossref
Dimitri Gerostamoulos, Linda Glowacki, Maria Pricone, Kerryn Crump, Matthew Di Rago, Samantha Joubert, Matthew J Lynch, Noel W Woodford & Olaf H Drummer. (2022) Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. Journal of Analytical Toxicology.
Crossref
Crossref
Konstantin A. Demin, Olga V. Kupriyanova, Vadim A. Shevyrin, Ksenia A. Derzhavina, Nataliya A. Krotova, Nikita P. Ilyin, Tatiana O. Kolesnikova, David S. Galstyan, Yurii M. Kositsyn, Abubakar-Askhab S. Khaybaev, Maria V. Seredinskaya, Yaroslav Dubrovskii, Raziya G. Sadykova, Maria O. Nerush, Mikael S. Mor, Elena V. Petersen, Tatyana Strekalova, Evgeniya V. Efimova, Savelii R. Kuvarzin, Konstantin B. Yenkoyan, Dmitrii V. Bozhko, Vladislav O. Myrov, Sofia M. Kolchanova, Aleksander I. Polovian, Georgii K. Galumov & Allan V. Kalueff. (2022)
Acute behavioral and Neurochemical Effects of Novel
N
-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish
. ACS Chemical Neuroscience 13:13, pages 1902-1922.
Crossref
Crossref
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
279
300
.
Laura Clancy, Morgan Philp, Ronald Shimmon & Shanlin Fu. (2020) Development and validation of a color spot test method for the presumptive detection of 25‐NBOMe compounds. Drug Testing and Analysis 13:5, pages 929-943.
Crossref
Crossref
Michal Ordak, Aleksandra Zmysłowska, Miłosz Bielski, Daniel Rybak, Maja Tomaszewska, Katarzyna Wyszomierska, Aleksandra Kmiec, Natalia Garlicka, Maria Zalewska, Michal Zalewski, Tadeusz Nasierowski, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2021) Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports. Frontiers in Psychiatry 12.
Crossref
Crossref
Tsuyoshi Okada, Katsutoshi Shioda, Akiko Makiguchi & Shiro Suda. (2020) Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats. International Journal of Neuropsychopharmacology 23:12, pages 811-820.
Crossref
Crossref
Christian B. M. Poulie, Anders A. Jensen, Adam L. Halberstadt & Jesper L. Kristensen. (2019) DARK Classics in Chemical Neuroscience: NBOMes. ACS Chemical Neuroscience 11:23, pages 3860-3869.
Crossref
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Funda InanTibor M. Brunt, Ramon R. ContrucciLaura HondebrinkEric J. F. Franssen. (2020) Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review. Therapeutic Drug Monitoring 42:2, pages 271-281.
Crossref
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Crossref
Sergio Armenta, Cristina Gil, Mireia Ventura & Francesc A. Esteve-Turrillas. (2020) Unexpected identification and characterization of a cathinone precursor in the new psychoactive substance market: 3′,4′-methylenedioxy-2,2-dibromobutyrophenone. Forensic Science International 306, pages 110043.
Crossref
Crossref
Sabrina Lehmann, Tobias Kieliba, Mario Thevis, Markus A. Rothschild & Katja Mercer-Chalmers-Bender. (2019) Fatalities associated with NPS stimulants in the Greater Cologne area. International Journal of Legal Medicine 134:1, pages 229-241.
Crossref
Crossref
Cristina Miliano, Matteo Marti, Nicholas Pintori, Maria Paola Castelli, Micaela Tirri, Raffaella Arfè & Maria Antonietta De Luca. (2019) Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. Frontiers in Pharmacology 10.
Crossref
Crossref
Shijia Chan, Jiahao Wu & Belinda Lee. (2019) Fatalities related to new psychoactive substances in Singapore—A case series. Forensic Science International 304, pages 109892.
Crossref
Crossref
Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell & Julia Lappin. (2019) Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia. Drug and Alcohol Dependence 204, pages 107556.
Crossref
Crossref
Hadil M. Elbardisy, Christopher W. Foster, Jack Marron, Ryan E. Mewis, Oliver B. Sutcliffe, Tarek S. Belal, Wael Talaat, Hoda G. Daabees & Craig E. Banks. (2019) Quick Test for Determination of N-Bombs (Phenethylamine Derivatives, NBOMe) Using High-Performance Liquid Chromatography: A Comparison between Photodiode Array and Amperometric Detection. ACS Omega 4:11, pages 14439-14450.
Crossref
Crossref
Monika Herian, Adam Wojtas, Katarzyna Kamińska, Paweł Świt, Anna Wach & Krystyna Gołembiowska. (2019) Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats. Neurotoxicity Research 36:1, pages 91-100.
Crossref
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Crossref
S. S. Barsegyan, A. N. Kiryushin, N. N. Eroshchenko, N. O. Tuaeva, A. E. Nosyrev & A. A. Kirilyuk. (2019) The detection of the 25B-NBOMe derivative of phenylethylamine in the biological material. Sudebno-meditsinskaya ekspertiza 62:2, pages 34.
Crossref
Crossref
Alys H Hunter, T Ayres, N Moreland & A Cox. (2018) Phantom menace: novel psychoactive substances and the UK Armed Forces. Journal of the Royal Army Medical Corps 164:6, pages 450-457.
Crossref
Crossref
Katharina Elisabeth Grafinger, Katja Stahl, Andreas Wilke, Stefan König & Wolfgang Weinmann. (2018)
In vitro
phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models
. Drug Testing and Analysis 10:10, pages 1607-1626.
Crossref
Crossref
Laura Hondebrink, Anne Zwartsen & Remco H.S. Westerink. (2018) Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?. Pharmacology & Therapeutics 182, pages 193-224.
Crossref
Crossref
Glayton A. Souza, Dilton M. Pimentel, Amanda B. Lima, Tiago J. Guedes, Luciano C. Arantes, Anderson C. de Oliveira, Raquel M. F. Sousa, Rodrigo A. A. Muñoz & Wallans T. P. dos Santos. (2018) Electrochemical sensing of NBOMes and other new psychoactive substances in blotting paper by square-wave voltammetry on a boron-doped diamond electrode. Analytical Methods 10:20, pages 2411-2418.
Crossref
Crossref
Kelly Francisco da Cunha, Marcos Nogueira Eberlin & Jose Luiz Costa. (2017) Development and validation of a sensitive LC–MS/MS method to analyze NBOMes in dried blood spots: evaluation of long-term stability. Forensic Toxicology 36:1, pages 113-121.
Crossref
Crossref
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances
413
439
.
RL Carhart-Harris & DJ Nutt. (2017) Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology 31:9, pages 1091-1120.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
Keith-Dane H. Temporal, Karen S. Scott, Amanda L.A. Mohr & Barry K. Logan. (2017) Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine. Journal of Analytical Toxicology 41:7, pages 646-657.
Crossref
Crossref
Matthew Valento & Jacob Lebin. (2017) Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones. Clinical Pediatric Emergency Medicine 18:3, pages 203-211.
Crossref
Crossref
Michael B. Gatch, Sean B. Dolan & Michael J. Forster. (2017) Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behavioural Pharmacology 28:5, pages 375-385.
Crossref
Crossref
Tibor Markus Brunt, Amanda Marie Atkinson, Thomas Nefau, Magali Martinez, Emmanuel Lahaie, Artur Malzcewski, Martin Pazitny, Vendula Belackova & Simon D. Brandt. (2017) Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price. International Journal of Drug Policy 44, pages 105-114.
Crossref
Crossref
Marek Wiergowski, Justyna Aszyk, Michał Kaliszan, Kamila Wilczewska, Jacek Sein Anand, Agata Kot-Wasik & Zbigniew Jankowski. (2017) Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC–MS/MS in case of severe intoxications. Journal of Chromatography B 1041-1042, pages 1-10.
Crossref
Crossref
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
283
311
.